Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Hemorrhage in Patients Prescribed Arixtra Compared to LMWH

NCT01064362 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01064362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01064362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Hemorrhage in Patients Prescribed Arixtra Compared to LMWH
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2010
Enrollment
13,442 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thrombosis, venous